{"abstract": "Congress wants a second look at how private firms profit from public research after Pfizer and the National Institutes of Health developed a potentially lucrative new drug.", "web_url": "https://www.nytimes.com/2013/03/19/business/questions-for-public-private-pact-that-led-to-xeljanz.html", "snippet": "Congress wants a second look at how private firms profit from public research after Pfizer and the National Institutes of Health developed a potentially lucrative new drug.", "lead_paragraph": "WASHINGTON \u2014 With automatic spending cuts cascading through the government, lawmakers are calling for a review of federal policies they say have allowed businesses to profit on government research with limited return for taxpayers or consumers.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/03/19/business/Pharma3/Pharma3-jumbo.jpg", "height": 660, "width": 336, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/03/19/business/Pharma3/Pharma3-superJumbo.jpg", "height": 660, "width": 336, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2013/03/19/business/Pharma3/Pharma3-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2013/03/19/business/Pharma3/Pharma3-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/03/19/business/Pharma3/Pharma3-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Seeking Profit for Taxpayers in Potential of New Drug", "kicker": null, "content_kicker": null, "print_headline": "Seeking Profit For Taxpayers In Potential Of New Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "National Institutes of Health", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 4, "major": "N"}, {"name": "persons", "value": "O'Shea, John J", "rank": 5, "major": "N"}, {"name": "subject", "value": "Federal Budget (US)", "rank": 6, "major": "N"}, {"name": "subject", "value": "Research", "rank": 7, "major": "N"}, {"name": "persons", "value": "Wyden, Ron", "rank": 8, "major": "N"}, {"name": "subject", "value": "ARTHRITIS", "rank": 9, "major": "N"}], "pub_date": "2013-03-19T00:38:01+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Jonathan Weisman", "person": [{"firstname": "Jonathan", "middlename": null, "lastname": "Weisman", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/7ce59094-bd45-598f-b1f7-df8fa2580916", "word_count": 1123, "uri": "nyt://article/7ce59094-bd45-598f-b1f7-df8fa2580916"}